Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial
Phase of Trial: Phase IV
Latest Information Update: 15 Oct 2013
At a glance
- Drugs Rifaximin (Primary) ; Lactulose
- Indications Bacterial infections; Hepatic encephalopathy
- Focus Therapeutic Use
- 15 Oct 2013 Results published in the Annals of Internal Medicine.
- 31 Jul 2013 New trial record
- 23 Jul 2013 Results published in the American Journal of Gastroenterology.